Phase II Clinical Development of New Drugs

This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful exec...

Full description

Bibliographic Details
Main Authors: Ting, Naitee (Author), Chen, Ding-Geng (Author), Ho, Shuyen (Author), Cappelleri, Joseph C. (Author)
Corporate Author: SpringerLink (Online service)
Format: Electronic eBook
Language:English
Published: Singapore : Springer Singapore : Imprint: Springer, 2017.
Series:ICSA Book Series in Statistics,
Subjects:
Online Access:Full Text via HEAL-Link
Description
Summary:This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
Physical Description:XVII, 241 p. 25 illus., 17 illus. in color. online resource.
ISBN:9789811041945
ISSN:2199-0980